JP2018048143A5 - - Google Patents

Download PDF

Info

Publication number
JP2018048143A5
JP2018048143A5 JP2017183651A JP2017183651A JP2018048143A5 JP 2018048143 A5 JP2018048143 A5 JP 2018048143A5 JP 2017183651 A JP2017183651 A JP 2017183651A JP 2017183651 A JP2017183651 A JP 2017183651A JP 2018048143 A5 JP2018048143 A5 JP 2018048143A5
Authority
JP
Japan
Prior art keywords
ring
group
methyl
urea
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017183651A
Other languages
English (en)
Japanese (ja)
Other versions
JP6627835B2 (ja
JP2018048143A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018048143A publication Critical patent/JP2018048143A/ja
Publication of JP2018048143A5 publication Critical patent/JP2018048143A5/ja
Application granted granted Critical
Publication of JP6627835B2 publication Critical patent/JP6627835B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017183651A 2014-10-24 2017-09-25 Kcnq2〜5チャネル活性化剤 Expired - Fee Related JP6627835B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014217540 2014-10-24
JP2014217540 2014-10-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016555419A Division JP6217866B2 (ja) 2014-10-24 2015-10-23 Kcnq2〜5チャネル活性化剤

Publications (3)

Publication Number Publication Date
JP2018048143A JP2018048143A (ja) 2018-03-29
JP2018048143A5 true JP2018048143A5 (OSRAM) 2018-11-15
JP6627835B2 JP6627835B2 (ja) 2020-01-08

Family

ID=55761020

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016555419A Active JP6217866B2 (ja) 2014-10-24 2015-10-23 Kcnq2〜5チャネル活性化剤
JP2017183651A Expired - Fee Related JP6627835B2 (ja) 2014-10-24 2017-09-25 Kcnq2〜5チャネル活性化剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016555419A Active JP6217866B2 (ja) 2014-10-24 2015-10-23 Kcnq2〜5チャネル活性化剤

Country Status (17)

Country Link
US (4) US9809544B2 (OSRAM)
EP (1) EP3210969B1 (OSRAM)
JP (2) JP6217866B2 (OSRAM)
KR (1) KR20170076673A (OSRAM)
CN (1) CN107108485B (OSRAM)
AU (1) AU2015336458B2 (OSRAM)
BR (1) BR112017008178A2 (OSRAM)
CA (1) CA2965467A1 (OSRAM)
ES (1) ES2871673T3 (OSRAM)
IL (1) IL251827B (OSRAM)
MX (1) MX373603B (OSRAM)
PH (1) PH12017500737B1 (OSRAM)
RU (1) RU2712163C2 (OSRAM)
SG (1) SG11201703284XA (OSRAM)
TW (1) TWI664166B (OSRAM)
WO (1) WO2016063990A1 (OSRAM)
ZA (1) ZA201703498B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170076673A (ko) * 2014-10-24 2017-07-04 오노 야꾸힝 고교 가부시키가이샤 Kcnq2∼5 채널 활성화제
JP6197971B1 (ja) * 2016-04-22 2017-09-20 小野薬品工業株式会社 Kcnq2〜5チャネル関連疾患の予防および/または治療剤
WO2017183723A1 (ja) * 2016-04-22 2017-10-26 小野薬品工業株式会社 Kcnq2~5チャネル活性化剤
MX2018012898A (es) * 2016-04-22 2019-01-30 Ono Pharmaceutical Co Polimorfismo cristalino del activador del canal controlado por voltaje de potasio de subfamilia kqt subtipos 2-5 (kcnq2-5).
WO2019124507A1 (ja) * 2017-12-21 2019-06-27 杏林製薬株式会社 夜間頻尿治療剤
CN109232380B (zh) * 2018-10-22 2021-08-10 新乡市润宇新材料科技有限公司 一种4-溴咔唑的合成方法
CN109232383B (zh) * 2018-12-04 2022-02-01 河南省科学院高新技术研究中心 一种合成4-溴咔唑的方法
SMT202400003T1 (it) * 2019-02-06 2024-03-13 Lilly Co Eli Derivati di 1-((2-(2,2,2-trifluoroetossi)piridin-4-il)metil)urea come potenziatori di kcnq
AU2021295422A1 (en) * 2020-06-25 2023-02-23 Idorsia Pharmaceuticals Ltd Cyclobutyl-urea derivatives
PE20250155A1 (es) * 2021-06-14 2025-01-22 Scorpion Therapeutics Inc Derivados de la urea que pueden ser utilizados para tratar el cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES442992A1 (es) * 1974-12-02 1977-08-01 Scherico Ltd Un procedimiento para preparar 2-anilino-oxazolinas.
CH623044A5 (en) * 1974-12-02 1981-05-15 Scherico Ltd Process for the preparation of novel anilino-2-oxazolines
US4058612A (en) * 1974-12-02 1977-11-15 Schering Corporation 6-(Polyhaloisopropyl)quinazoline-2,4-diones
ATE509014T1 (de) 2001-01-26 2011-05-15 Chugai Pharmaceutical Co Ltd Malonyl coa-decarboxylase inhibitoren als stoffwechselmodulatoren
AU2002236830A1 (en) * 2001-01-26 2002-08-06 Chugai Seiyaku Kabushiki Kaisha Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
AU2002358700A1 (en) * 2001-12-26 2003-07-15 Bayer Aktiengesellschaft Urea derivatives as vr1- antagonists
JP2003192660A (ja) * 2001-12-26 2003-07-09 Bayer Ag 尿素誘導体
WO2004064730A2 (en) 2003-01-14 2004-08-05 Cytokinetics, Inc. Compounds, compositions and methods
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
AU2006322461A1 (en) * 2005-09-09 2007-06-14 H. Lundbeck A/S Pyrimidine derivatives and their use as KCNQ potassium channels openers
UA97847C2 (ru) 2007-08-01 2012-03-26 Х. Луннбек А/С Применение соединений, которые открывают калиевые каналы kcnq, для лечения дефицита внимания/гиперактивности (adhd) или агрессии
JP2010037311A (ja) 2008-08-08 2010-02-18 Bayer Cropscience Ag 新規殺虫性アシルアミノベンズアミド誘導体
WO2010065333A1 (en) 2008-12-01 2010-06-10 Lexicon Pharmaceuticals, Inc. 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds for the treatment of osteoporosis
TWI475020B (zh) * 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
AU2011203897B2 (en) 2010-01-11 2016-11-17 Inotek Pharmaceuticals Corporation Combination, kit and method of reducing intraocular pressure
WO2011085351A2 (en) * 2010-01-11 2011-07-14 The Johns Hopkins University Method of treating kcnq related disorders
CN103842357A (zh) * 2011-07-26 2014-06-04 格吕伦塔尔有限公司 作为类香草素受体配体的被取代的、含有杂芳环吡唑的羧酰胺和脲衍生物
KR102006612B1 (ko) * 2011-11-02 2019-08-02 베링거 인겔하임 인터내셔날 게엠베하 헤테로사이클릭 화합물, 상기 화합물을 포함하는 약제, 이의 용도, 및 이의 제조 방법
KR20170076673A (ko) * 2014-10-24 2017-07-04 오노 야꾸힝 고교 가부시키가이샤 Kcnq2∼5 채널 활성화제

Similar Documents

Publication Publication Date Title
JP2018048143A5 (OSRAM)
RU2017117566A (ru) Активатор kcnq2-5 каналов
RU2011108281A (ru) Трипиридилкарбоксамидные антагонисты орексиновых рецепторов
HRP20200538T1 (hr) Derivati pirimidina za liječenje virusnih infekcija
JP2015529224A5 (OSRAM)
JP2014511892A5 (OSRAM)
JP2017533968A5 (OSRAM)
JP2015520769A5 (OSRAM)
JP2015537015A5 (OSRAM)
JP2017528498A5 (OSRAM)
JP2016519072A5 (OSRAM)
JP2012507566A5 (OSRAM)
JP2016522172A5 (OSRAM)
JP2016516699A5 (OSRAM)
JP2017528467A5 (OSRAM)
RU2014113679A (ru) N-(2-амино-6,6-дифтор-4,4а,5,6,7,7а-гексагидро-циклопента[e][1,3]оксазин-4-ил)-фенил)-амиды в качестве ингибиторов бета-секретазы 1
JP2016505512A5 (OSRAM)
JP2016525075A5 (OSRAM)
JP2017514855A5 (OSRAM)
RU2017101829A (ru) Пиразоловые соединения в качестве модуляторов fshr и пути их применения
RU2017116196A (ru) 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1
JP2017517538A5 (OSRAM)
JP2019518770A5 (OSRAM)
RU2018114077A (ru) Биарильное производное и содержащее его лекарственное средство
JP2015521195A5 (OSRAM)